July 16,
2018 13480 13480 
The date of the next Cosmetic Therapy exam is Monday, August 27, 2018. The application must be submitted before 5 p.m. on Monday, August 13. Click here for information and to submit an application.
.jpg?ver=sbX19zzlUh2fiFr4ctulDA%3d%3d)
July 16,
2018 14177 14177
OARRS prescriber users now have access to an additional tool on their OARRS dashboard. Prescribers will be able to regularly generate their mandatory use compliance reports in OARRS. This tool will allow for prescribers to generate monthly compliance reports for patients that were prescribed an opioid or a benzodiazepene for more than a seven days' supply and automatically view which patients were not queried by you or your delegate.
To view your report:
-
-
Click Menu
-
Select MyRx
-
Click My Mandatory Use Compliance tab
Monthly compliance reports will include the date when the report was compiled and what dates are contained in the report. Use this infographic guide as you navigate requesting the report.
June 20,
2018 13697 13697
The Medical Board is seeking comments on the initial review of two rules. The proposed language for each rule can be found by clicking on the links below.
Comments on the rules should be submitted to Sallie Debolt, Senior Counsel, State Medical Board of Ohio at Sallie.Debolt@med.ohio.gov by July 9th.
June 18,
2018 13041 13041
The National Transportation Safety Board (NTSB) is asking health care providers across the country to counsel their patients regarding the effect medication use may have on their ability to safely operate a vehicle.
The use of over-the-counter (OTC), prescription, and illicit drugs is increasing in the US population. The NTSB is concerned about the possible safety implications of increased drug use in all modes of transportation, but data about drug use by vehicle operators is limited to a small proportion of operators and a short list of drugs. Therefore, NTSB did a study of airline pilots and accidents- a mode of transportation where there was a substantial data set available. The findings of that study prompted the NTSB to reach out to prescribers across the country.
NTSB urges prescribers to highlight the importance of routinely discussing with patients the effect their diagnosed medical conditions or recommended drugs may have on their ability to safely operate a vehicle in any mode of transportation.
In addition, the NTSB has asked regulatory boards to incorporate reminders about these important discussions with patients in prescribing guidelines. The State Medical Board of Ohio’s resolution was adopted on June 13, 2018:
Resolution: Guideline for Patient Discussion Regarding Vehicle Operation When Prescribing Controlled Substances for Pain
Adopted June 13, 2018
The Board hereby makes the following recommendation to our licensed health care providers when prescribing controlled substances for pain. It is recommended that the prescribers licensed by the Board inform the patient of the effect the patient’s medication may have on the patient’s ability to safely operate a vehicle. This recommendation is consistent with the National Transportation Safety Board Safety Recommendation, I-14-1 and I-14-2.
NTSB an independent federal agency charged by Congress with investigating every civil aviation accident in the United States and significant accidents in other modes of transportation to determine the probable cause of the accidents. In consideration of investigative findings, the NTSB issues safety recommendations aimed at preventing future accidents and saving lives.
Click here for a link to the resolution.